News

Learn more about our company, latest developments in clinical diagnostics, and scientific breaktroughs in the rare disease field.

Stay on top, subscribe to our newsletter and follow us on social media.

  1. News & press releases

News


CENTOGENE and Denali Therapeutics (NASDAQ: DNLI) today announced a strategic collaboration for the global identification...


Joint drug discovery projects combine CENTOGENE’s patient access and biomarker expertise with Evotec's leading IPSC...


We are proud to have been honored with the award from the Federal State Government of Mecklenburg-Vorpommern in the...


CENTOGENE announced today a partnering with the Medical Faculties of the Universities of Greifswald and Rostock for the...


CENTOGENE announced today the opening of its first U.S. based rare disease laboratory in Cambridge, Massachusetts.  The...


CENTOGENE, driving the diagnostic workflows and individualized therapeutic decisions not only in rare diseases but also...


CENTOGENE, the worldwide leader in using genetic and proteomic knowledge to enable patients, clinicians and...


CENTOGENE, the worldwide leader in using genetic and proteomic knowledge to enable patients, clinicians and...


Collaboration Builds on Genetic Identification of Patients with Sjögren-Larsson Syndrome (SLS) in a Worldwide Cohort...


Dr. Arndt Rolfs talks at ECRD about speeding up the rare disease knowledge and information eco-system based on proteomic...